Phacilitate Leaders Forum

17th - 18th SEPTEMBER 2019


Cell and gene therapy manufacturing capacities in Europe 2017

Cell and gene therapy manufacturing capacities in Europe 2017

Without capacity, manufacturing expertise, innovation and partnerships, advanced therapies cannot be commercialised nor delivered to patients.

Manufacturing and process development for cell and gene therapies is growing rapidly in Europe…but so is demand.

Ensuring enough manufacturing capacity is now critical, this infographic provides information about where and when manufacturing capacity is available in Europe, along with in-depth detail about the facilities, clean rooms and product types.

This map is interactive!

manufacturing capacities in europe map

Simply click on the site you’d like to explore and when you want to get back to the map view you can hit the blue box in the top right corner.


  • Real thinking forward combining experts in the field from manufacturing, regulatory and value vision” – “great network with strong experience and sharing risks & opportunities
    Jean-Philippe Combal
    GenSight Biologics
  • The conference consistently proves to be a great forum for networking with industry leaders in the development of cellular and gene therapies as well as vendors for important technologies and services.
    Michael Covington
    Juno Therapeutics, Inc
  • It was a very interesting event as all participants, including speakers were ready to exchange, even on the most challenging subjects such as reimbursement, GMP guidance
    Bertrand Alexandre
  • Phacilitate EU delivered it's promise and more, the topics discussed were highly relevant, with very good and professional speakers and panelists. You will see me next year in Berlin.
    Dr Ohad Karnieli
    Karnieli Ltd